Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open-Label, Dose Escalation and Expansion Study of STX-0712 in Patients With Advanced Hematologic Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06950034
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:28.938548+00:00
Published At
2026-02-09T00:00:00+00:00
Record Updated At
2026-02-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Chronic Myelomonocytic Leukemia", "Chronic Myelomonocytic Leukemia (CMML)", "Chronic Myelomonocytic Leukemia-1", "Chronic Myelomonocytic Leukemia-2", "Refractory Chronic Myelomonocytic Leukemia", "CMML", "Acute Myeloid Leukemia", "Acute Myeloid Leukemia (AML)", "Acute Myeloid Leukemia Post Cytotoxic Therapy", "Acute Myeloid Leukemias", "Refractory Acute Myeloid Leukemia (AML)", "Acute Monocytic Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-09"
protocolSection.identificationModule.nctId
"NCT06950034"
protocolSection.identificationModule.officialTitle
"A Phase 1, Open-Label, Dose Escalation and Expansion Study of STX-0712 in Patients With Advanced Hematologic Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Chronic Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia (CMML) (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia-1 (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia-2 (protocolSection.conditionsModule.conditions)
  • Refractory Chronic Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • CMML (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia Post Cytotoxic Therapy (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemias (protocolSection.conditionsModule.conditions)
  • Refractory Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
  • Acute Monocytic Leukemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.